Related references
Note: Only part of the references are listed.Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis
Guanmei Cao et al.
EUROPEAN RADIOLOGY (2018)
Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis
Ivana Bjelobaba et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
Katharina Birkner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Contribution of EAE to understanding and treating multiple sclerosis
Amy E. Lovett-Racke
JOURNAL OF NEUROIMMUNOLOGY (2017)
Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
Chai K. Lim et al.
SCIENTIFIC REPORTS (2017)
Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages
Q. Yang et al.
CELL DEATH AND DIFFERENTIATION (2016)
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis
Niamh Cawley et al.
BRAIN (2015)
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
Laila M. Poisson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury
T. Noro et al.
CELL DEATH & DISEASE (2015)
A metabolomic approach to identifying platinum resistance in ovarian cancer
Laila M. Poisson et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis
S. N. Reinke et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis
Alex M. Dickens et al.
NEUROLOGY (2014)
Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology, and Neuro-Oncology
Paul L. Wood
NEUROPSYCHOPHARMACOLOGY (2014)
Potential of Urinary Metabolites for Diagnosing Multiple Sclerosis
Teklab Gebregiworgis et al.
ACS CHEMICAL BIOLOGY (2013)
The Emerging Role of p38 Mitogen-Activated Protein Kinase in Multiple Sclerosis and Its Models
Dimitry N. Krementsov et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology
Conor Mc Guire et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis
Lena Melamud et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Tyrosine hydroxylase and regulation of dopamine synthesis
S. Colette Daubner et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis
Paul E. Polak et al.
BRAIN (2011)
Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy
Warwick B. Dunn et al.
CHEMICAL SOCIETY REVIEWS (2011)
Isoprenoid biosynthesis in multiple sclerosis
Göran Steen et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Animal models of multiple sclerosis-Potentials and limitations
Eilhard Mix et al.
PROGRESS IN NEUROBIOLOGY (2010)
Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity
Narender Nath et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
A new track for understanding the pathogenesis of multiple sclerosis: From the perspective of early developmental deficit caused by the potential 5-HT deficiency in individuals in high-latitude areas
Xiaoming Gong et al.
MEDICAL HYPOTHESES (2008)
Inflammatory Multiple-Sclerosis Plaques Generate Characteristic Metabolic Profiles in Cerebrospinal Fluid
Norbert W. Lutz et al.
PLOS ONE (2007)
Experimental models of multiple sclerosis
H. Lassmann
REVUE NEUROLOGIQUE (2007)
A branched-chain organic acid linked to multiple sclerosis: First identification by NMR spectroscopy of CSF
Norbert W. Lutz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Graph-based methods for analysing networks in cell biology
Tero Aittokallio et al.
BRIEFINGS IN BIOINFORMATICS (2006)
Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B12:: mechanism of action and clinical importance:: roles of the locus coeruleus and central noradrenergic systems
C Loder et al.
MEDICAL HYPOTHESES (2002)
A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the Cari Loder regime) in the treatment of multiple sclerosis
DT Wade et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Share Paper
